Recurrent hypoventilation and respiratory failure during gabapentin therapy [6]

Journal of the American Geriatrics Society

Volumn 49, Issue 4, 2001, Pages 498-

  Batoon, S B ^a   Vela, A T ^a   Dave, D ^a   Wahid, Z ^a  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; GABAPENTIN; IPRATROPIUM BROMIDE; LEVOFLOXACIN; SALBUTAMOL; STEROID; ZOLPIDEM;

AGED; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; FOLLOW UP; HUMAN; HYPOVENTILATION; LETTER; MALE; PERIPHERAL NEUROPATHY; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ACETIC ACIDS; AGED; AMINES; ANALGESICS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOVENTILATION; LUNG DISEASES, OBSTRUCTIVE; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; RESPIRATORY INSUFFICIENCY;

EID: 0035040828     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2001.49105.x     Document Type: Letter

References (10)

1. Gabapentin for the management of agitation
2. Gabapentin for behavioral agitation in Alzheimer's disease
3. Gabapentin for the management of postherpetic neuralgia: A randomized controlled trial
4. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
5. Gabapentin for idiopathic trigeminal neuralgia: Report of two cases
6. Successful treatment of reflex sympathetic dystrophy with gabapentin
7. Emerging perspectives on the mechanism of action of gabapentin
8. Clinical pharmacokinetics of gabapentin
9. Clinical efficacy and safety of gabapentin